Company Search:
Advanced Search
Sponsored Links
10X Genomics Inc Company Snapshot
10X Genomics Inc operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares 10X Genomics Inc with three other companies in this sector in the United States: Moderna Inc (2018 sales of $135.07 million of which 100% was Pharmaceutical), Intrexon Corp ($160.57 million of which 100% was Synthetic Biology), and Halozyme Therapeutics, Inc. ($151.86 million of which 100% was Biopharmaceutical).

Sales Analysis.
  Stock Performance Chart for 10X Genomics Inc
  Stock Data: Recent Stock Performance:
  Current Price (11/15/2019): 67.85
(Figures in U.S. Dollars)
1 Week 21.8%   13 Weeks 29.2%  
4 Weeks n/a   52 Weeks n/a  
10X Genomics Inc Key Data:
  Ticker: TXG Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2018 Sales 146,313,000
(Year Ending Jan 2019).
Employees: 390
  Currency: U.S. Dollars Market Cap: 6,525,131,379
  Fiscal Yr Ends: December Shares Outstanding: 96,169,954
  Share Type: Common Closely Held Shares: N/A
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.